These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 35757728)

  • 1. The Prognostic and Immunotherapeutic Significance of AHSA1 in Pan-Cancer, and Its Relationship With the Proliferation and Metastasis of Hepatocellular Carcinoma.
    Li W; Liu J
    Front Immunol; 2022; 13():845585. PubMed ID: 35757728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AHSA1 Regulates Hepatocellular Carcinoma Progression via the TGF-β/Akt-Cyclin D1/CDK6 Pathway.
    Gao Y; Li Y; Liu Z; Dong Y; Yang S; Wu B; Xiao M; Chen C; Wen Y; Chen L; Jiang H; Yao Y
    J Hepatocell Carcinoma; 2023; 10():2021-2036. PubMed ID: 38022728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma.
    Cai J; Zhou M; Xu J
    World J Surg Oncol; 2021 Aug; 19(1):241. PubMed ID: 34389000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic analysis of the role of LDHs subtype in pan-cancer demonstrates the importance of LDHD in the prognosis of hepatocellular carcinoma patients.
    Wang S; Wu X; Wu X; Cheng J; Chen Q; Qi Z
    BMC Cancer; 2024 Jan; 24(1):156. PubMed ID: 38291366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
    Huang S; Sun L; Hou P; Liu K; Wu J
    Front Immunol; 2022; 13():944898. PubMed ID: 36148220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAC1 serves as a prognostic factor and correlated with immune infiltration in liver hepatocellular carcinoma.
    Li Y; Gu A; Yang L; Wang Q
    J Cancer Res Clin Oncol; 2024 Sep; 150(9):418. PubMed ID: 39264423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of RHBDF2 in Pan-Cancer, and its correlation with cell Adhesion of Hepatocellular Carcinoma.
    Gong H; Zhang Y; Chen X; Cao X; Tang L; Wang Y
    Biotechnol Genet Eng Rev; 2024 Oct; 40(2):1024-1048. PubMed ID: 36943153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pan-cancer analysis suggests histocompatibility minor 13 is an unfavorable prognostic biomarker promoting cell proliferation, migration, and invasion in hepatocellular carcinoma.
    Liu J; Li W; Wu L
    Front Pharmacol; 2022; 13():950156. PubMed ID: 36046831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis.
    Xiao H; Wang B; Xiong HX; Guan JF; Wang J; Tan T; Lin K; Zou SB; Hu ZG; Wang K
    J Cell Physiol; 2021 Apr; 236(4):2572-2591. PubMed ID: 32853412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Pyroptosis-Related Signature Composed of GSDMC Predicts Prognosis and Contributes to Growth and Metastasis of Hepatocellular Carcinoma.
    Li M; Jiang Q; Liu X; Han L; Chen S; Xue R
    Front Biosci (Landmark Ed); 2023 Oct; 28(10):235. PubMed ID: 37919059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AHSA1 Promotes Proliferation and EMT by Regulating ERK/CALD1 Axis in Hepatocellular Carcinoma.
    Zhang J; Ren Z; Zheng D; Song Z; Lin J; Luo Y; Zou X; Pan Y; Qi N; Li A; Liu X
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Biological Function of POLA2 in Hepatocellular Carcinoma.
    Yang Z; Shen X; Wang Z; Li R; Hou W; Liu Z; Gao Y; Zhu C; Qin X
    Comb Chem High Throughput Screen; 2024; 27(12):1758-1775. PubMed ID: 37861044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a Pyroptosis-Related Prognostic Signature Combined With Experiments in Hepatocellular Carcinoma.
    Li H; Li T; Zhang X
    Front Mol Biosci; 2022; 9():822503. PubMed ID: 35309514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARPC2: A Pan-Cancer Prognostic and Immunological Biomarker That Promotes Hepatocellular Carcinoma Cell Proliferation and Invasion.
    Huang S; Dong C; Li D; Xu Y; Wu J
    Front Cell Dev Biol; 2022; 10():896080. PubMed ID: 35733852
    [No Abstract]   [Full Text] [Related]  

  • 17. Scinderin is a potential prognostic biomarker and correlated with immunological regulation: from pan-cancer analysis to liver hepatocellular carcinoma.
    Zhai S; Li Y; Yang Y; Lang W; Liu X; Liu K; Qu J; Zhu L
    Front Immunol; 2024; 15():1361657. PubMed ID: 39108273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Pyroptosis-Based Prognostic Model for Immune Microenvironment Estimation of Hepatocellular Carcinoma.
    Chen Z; Zou Y; Zhang Y; Chen Z; Wu F; Jin H; Shi N
    Dis Markers; 2022; 2022():8109771. PubMed ID: 35047095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
    Ma C; Kang W; Yu L; Yang Z; Ding T
    Front Oncol; 2020; 10():590006. PubMed ID: 33363020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.